Tissue conduction communication (TCC) transmission

US9636511B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9636511-B2
Application numberUS-201514603938-A
CountryUS
Kind codeB2
Filing dateJan 23, 2015
Priority dateJan 23, 2015
Publication dateMay 2, 2017
Grant dateMay 2, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal includes a TCC transmitter module configured to generate the TCC signal and transmit the TCC signal via a plurality of electrodes. The TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude and the frequency are configured to avoid stimulation of tissue of the patient. The TCC transmitter module comprises protection circuitry coupled between a current source and the plurality of electrodes, wherein the protection circuitry is configured to protect the signal generator from an external anti-tachyarrhythmia shock delivered to the patient.

First claim

Opening claim text (preview).

What is claimed is: 1. An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal, the ICD comprising: a housing; a plurality of electrodes; and a signal generator within the housing, the signal generator comprising: a shock module coupled to the plurality of electrodes, wherein the shock module is configured to generate an anti-tachyarrhythmia shock and deliver the anti-tachyarrhythmia shock to a patient via the plurality of electrodes; and a TCC transmitter module coupled to the plurality of electrodes, wherein the TCC transmitter module is configured to generate the TCC signal and transmit the TCC signal via the plurality of electrodes, wherein the TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude or the frequency is configured to avoid stimulation of tissue of the patient by the TCC signal, and wherein the TCC transmitter module comprises: a power source configured to deliver current having the amplitude to the plurality of electrodes; polarity switching circuitry coupled to the power source, wherein the polarity switching circuitry is configured to switch the polarity of the current at the frequency; and protection circuitry coupled between the power source and the plurality of electrodes, wherein the protection circuitry is configured to protect the TCC transmitter module and other circuitry within the housing of the ICD from an anti-tachyarrhythmia shock delivered to the patient by the shock module or an external device, and a standoff voltage of the protection circuitry is greater than 2000 volts (V). 2. The ICD of claim 1 , wherein the frequency is at least 100 kilohertz (kHz). 3. The ICD of claim 1 , wherein the frequency is within a range from 150 kilohertz (kHz) to 200 kHz. 4. The ICD of claim 3 , wherein the polarity switching circuitry is configured to toggle the frequency between 150 kHz and 200 kHz. 5. The ICD of claim 1 , wherein the amplitude is within a range from 5 milliamps (mA) to 40 mA. 6. The ICD of claim 1 , wherein the amplitude is within a range from 5 milliamps (mA) 10 mA. 7. The ICD of claim 1 , wherein the protection circuitry comprises: a first capacitor coupled between the power source and a first electrode of the plurality of electrodes; and a second capacitor coupled between the power source and a second electrode of the plurality of electrodes. 8. The ICD of claim 7 , wherein the protection circuitry comprises a first LC circuit that comprises the first capacitor and a first inductor. 9. The ICD of claim 8 , wherein the protection circuitry comprises a second LC circuit that comprises the second capacitor and a second inductor. 10. The ICD of claim 8 , wherein the frequency of the TCC signal is within a pass-band of the first LC circuit. 11. The ICD of claim 10 , wherein the pass-band is within a range from 150 kilohertz (kHz) to 200 kHz. 12. The ICD of claim 1 , wherein the housing comprises a first electrode of the plurality of electrodes, and a coil electrode coupled to the ICD by a lead comprises a second electrode of the plurality of electrodes. 13. The ICD of claim 1 , further comprising: an antenna; and a radio-frequency (RF) telemetry module configured to transmit and receive RF telemetry signals via the antenna, wherein the RF telemetry module is further configured to modulate the TCC signal, and at least one of the power source or the polarity switching circuitry of the TCC transmitter module generates the TCC signal according to the modulation. 14. The ICD of claim 1 , wherein the ICD comprises an extravascular ICD, and the plurality of electrodes are configured for extravascular implantation. 15. An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal, the ICD comprising: a housing; a plurality of electrodes; and a signal generator within the housing, the signal generator comprising: a shock module coupled to the plurality of electrodes, wherein the shock module is configured to generate an anti-tachyarrhythmia shock and deliver the anti-tachyarrhythmia shock to a patient via the plurality of electrodes; and a TCC transmitter module coupled to the plurality of electrodes, wherein the TCC transmitter module is configured to generate the TCC signal and transmit the TCC signal via the plurality of electrodes, wherein the TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude or the frequency is configured to avoid stimulation of tissue of the patient by the TCC signal, and wherein the TCC transmitter module comprises: a power source configured to deliver current having the amplitude to the plurality of electrodes; polarity switching circuitry coupled to the power source, wherein the polarity switching circuitry is configured to switch the polarity of the current at the frequency; and protection circuitry coupled between the power source and the plurality of electrodes, wherein the protection circuitry is configured to protect the TCC transmitter module and other circuitry within the housing of the ICD from an anti-tachyarrhythmia shock delivered to the patient by the shock module or an external device, wherein the power source and the protection circuitry comprise at least two common high-voltage switches, wherein a first high-voltage switch of the at least two common high-voltage switches is coupled to a first electrode of the plurality of electrodes, and a second high-voltage switch of the at least two common high-voltage switches is coupled to a second electrode of the plurality of electrodes, and wherein cathodes of the first and second high-voltage switches deliver current to the plurality of electrodes. 16. The ICD of claim 15 , wherein a standoff voltage of the protection circuitry is greater than 2000 volts (V). 17. An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal, the ICD comprising: a housing, a plurality of electrodes, and a signal generator within the housing, the signal generator comprising: a shock module coupled to the plurality of electrodes, wherein the shock module is configured to generate an anti-tachyarrhythmia shock and deliver the anti-tachyarrhythmia shock to a patient via the plurality of electrodes, and a TCC transmitter module coupled to the plurality of electrodes, wherein the TCC transmitter module is configured to generate the TCC signal and transmit the TCC signal via the plurality of electrodes, wherein the TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude or the frequency is configured to avoid stimulation of tissue of the patient by the TCC signal, and wherein the TCC transmitter module comprises: a power source configured to deliver current having the amplitude to the plurality of electrodes, polarity switching circuitry coupled to the power source, wherein the polarity switching circuitry is configured to switch the polarity of the current at the frequency, wherein the polarity switching circuitry comprises: a first transistor coupled to a first electrode of the plurality of electrodes; and a second transistor coupled to a second electrode of the plurality of electrodes, and wherein on-off states of the first and second transistors are oppositely alternated at the frequency to switch the polarity of the current at the frequency; and protection circuitry coupled between the power sou

Assignees

Inventors

Classifications

  • Pacing therapy · CPC title

  • for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

  • Power supply (A61N1/378 takes precedence) · CPC title

  • A61N1/3956Primary

    Implantable devices for applying electric shocks to the heart, e.g. for cardioversion · CPC title

  • in combination with another heart therapy · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9636511B2 cover?
An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal includes a TCC transmitter module configured to generate the TCC signal and transmit the TCC signal via a plurality of electrodes. The TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude and the frequency are configur…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/39622. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).